<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Existing <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> biomarkers are insufficient for providing a quick and accurate diagnosis, which is critical for a good prognosis </plain></SENT>
<SENT sid="1" pm="."><plain>More appropriate biomarkers are thus needed </plain></SENT>
<SENT sid="2" pm="."><plain>To identify new <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> biomarker candidates, we conducted a comprehensive differential proteomic analysis of six <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> cell lines and a <z:mpath ids='MPATH_458'>normal</z:mpath> cell line, utilizing a fluorogenic derivatization-liquid chromatography-tandem mass spectrometry (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">FD</z:e>-LC-MS/MS) approach </plain></SENT>
<SENT sid="3" pm="."><plain>Two sets of intracellular biomarker candidates were identified: one for <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e>, and the other for <z:e sem="disease" ids="C0948380" disease_type="Neoplastic Process" abbrv="">metastatic colorectal cancer</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain>Our results suggest that cooperative expression of FABP5 and cyclophilin A might be linked to Her2 signaling </plain></SENT>
<SENT sid="5" pm="."><plain>Upregulation of LDHB and downregulation of GAPDH suggest the existence of a specific nonglycolytic energy production pathway in <z:e sem="disease" ids="C0948380" disease_type="Neoplastic Process" abbrv="">metastatic colorectal cancer</z:e> cells </plain></SENT>
<SENT sid="6" pm="."><plain>Downregulation of 14-3-3ζ/δ, cystatin-B, Ran and <z:chebi fb="0" ids="15033">thioredoxin</z:chebi> could be a result of their secretion, which then stimulates <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> via activity in the sera and ascitic fluids </plain></SENT>
<SENT sid="7" pm="."><plain>We propose a possible flow scheme to describe the dynamics of protein expression in <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> cells leading to <z:e sem="disease" ids="C0178874" disease_type="Neoplastic Process" abbrv="">tumor progression</z:e> and <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> via cell proliferation, <z:mpath ids='MPATH_177'>angiogenesis</z:mpath>, disorganization of actin filaments and epithelial-mesenchymal transition </plain></SENT>
<SENT sid="8" pm="."><plain>Our results suggest that <z:e sem="disease" ids="C0009404" disease_type="Neoplastic Process" abbrv="">colorectal tumor</z:e> progression may be regulated by signaling mediated by Her2, <z:mp ids='MP_0005039'>hypoxia</z:mp>, and TGFβ </plain></SENT>
</text></document>